Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Jun 19;21(8):1348–1353. doi: 10.1158/1055-9965.EPI-12-0495

Table 4.

Association of Prostate Cancer with HOXB13 G84E in strata of age of diagnosis, and disease aggressiveness.

Affected in Pedigreea Stratum Carrier Rate (%) OR (95% CI) P
≥ 2 ≤ 60b 8 of 435 (0.018) 9.9 (1.4 – 68.6) 0.020
≥ 2 ≥ 61 8 of 423 (0.019) 7.7 (1.6 – 37.0) 0.011
≥ 2 Gleason ≤ 6 7 of 433 (0.016) 6.4 (1.3 – 32.1) 0.023
≥ 2 Gleason ≥ 7 9 of 400 (0.023) 9.9 (2.1 – 46.0) 3.5 × 10−3
≥ 2 ≥ pT3, N1, or M1 4 of 175 (0.023) 9.7 (1.8 – 53.5) 9.2 × 10−3
≥ 3 ≤ 60 5 of 177 (0.028) 13.9 (1.8 – 105.5) 0.011
≥ 3 ≥ 61 4 of 152 (0.026) 10.2 (1.8 – 57.8) 8.9 × 10−3
≥ 3 Gleason ≤ 6 5 of 180 (0.028) 11.3 (2.0 – 62.4) 5.5 × 10−3
≥ 3 Gleason ≥ 7 4 of 135 (0.030) 13.1 (2.4 – 72.4) 3.2 × 10−3
≥ 3 ≥ pT3, N1, or M1 3 of 57 (0.053) 23.3 (3.8 – 143.0) 6.8 × 10−4
a

First and second degree relatives (0, controls; 1, case probands with no others in pedigree affected; 2, case probands with one additional in pedigree affected, etc).

b

Proband age of diagnosis.